Immune defects promoting CLL [ 2014 - 2017 ]

Research Grant

Researchers: Prof Fabienne Mackay (Principal investigator) ,  A/Pr Stephen Ting

Brief description Chronic Lymphocytic Leukemia (CLL) is a very common blood cancer. Leukaemic tumour cells actively shut down key immune defences in patients who are very prone to severe infections. Current chemotherapies further immuno-compromise CLL patients and over a quarter will die from an infection despite having responded to cancer treatments. We propose that restoring key immune functions in CLL is key to improve resistance to infection and restore natural anti-cancer immunity.

Funding Amount $AUD 557,565.00

Funding Scheme Project Grants

Notes Standard Project Grant